메뉴 건너뛰기




Volumn 29, Issue 7, 2010, Pages 867-871

Superinfection during treatment of nosocomial infections with tigecycline

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CASPOFUNGIN; COLISTIN; ERTAPENEM; GENTAMICIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TIGECYCLINE; ANTIINFECTIVE AGENT; MINOCYCLINE;

EID: 77955429497     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-0942-y     Document Type: Article
Times cited : (17)

References (15)
  • 1
    • 2542444502 scopus 로고    scopus 로고
    • Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936)
    • DOI 10.1128/AAC.48.6.2179-2184.2004
    • T Hirata A Saito K Nishino N Tamura A Yamaguchi 2004 Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936) Antimicrob Agents Chemother 48 2179 2184 10.1128/AAC.48.6.2179-2184.2004 1:CAS:528:DC%2BD2cXks1yqtLk%3D 15155219 (Pubitemid 38691616)
    • (2004) Antimicrobial Agents and Chemotherapy , vol.48 , Issue.6 , pp. 2179-2184
    • Hirata, T.1    Saito, A.2    Nishino, K.3    Tamura, N.4    Yamaguchi, A.5
  • 2
    • 0037229072 scopus 로고    scopus 로고
    • Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates
    • DOI 10.1128/AAC.47.1.400-404.2003
    • D Milatovic FJ Schmitz J Verhoef AC Fluit 2003 Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates Antimicrob Agents Chemother 47 400 404 10.1128/AAC.47.1.400- 404.2003 1:CAS:528:DC%2BD3sXis12ksw%3D%3D 12499224 (Pubitemid 36070396)
    • (2003) Antimicrobial Agents and Chemotherapy , vol.47 , Issue.1 , pp. 400-404
    • Milatovic, D.1    Schmitz, F.-J.2    Verhoef, J.3    Fluit, A.C.4
  • 3
    • 27144454645 scopus 로고    scopus 로고
    • Safety and efficacy of tigecycline in treatment of skin and skin structure infections: Results of a double-blind phase 3 comparison study with vancomycin-aztreonam
    • DOI 10.1128/AAC.49.11.4658-4666.2005
    • J Breedt J Teras J Gardovskis FJ Maritz T Vaasna DP Ross M Gioud-Paquet N Dartois EJ Ellis-Grosse E Loh 2005 Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam Antimicrob Agents Chemother 49 4658 4666 10.1128/AAC.49.11.4658-4666.2005 1:CAS:528:DC%2BD2MXht1Siu73O 16251309 (Pubitemid 41552597)
    • (2005) Antimicrobial Agents and Chemotherapy , vol.49 , Issue.11 , pp. 4658-4666
    • Breedt, J.1    Teras, J.2    Gardovskis, J.3    Maritz, F.J.4    Vaasna, T.5    Ross, D.P.6    Gioud-Paquet, M.7    Dartois, N.8    Ellis-Grosse, E.J.9    Loh, E.10
  • 5
    • 23944505501 scopus 로고    scopus 로고
    • Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial
    • DOI 10.1016/j.ijid.2005.05.003, PII S1201971205000986
    • S Sacchidanand RL Penn JM Embil ME Campos D Curcio E Ellis-Grosse E Loh G Rose 2005 Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: results from a phase 3, randomized, double-blind trial Int J Infect Dis 9 251 261 10.1016/j.ijid.2005.05.003 1:CAS:528:DC%2BD2MXhtFegt7%2FN 16099700 (Pubitemid 41196869)
    • (2005) International Journal of Infectious Diseases , vol.9 , Issue.5 , pp. 251-261
    • Sacchidanand, S.1    Penn, R.L.2    Embil, J.M.3    Campos, M.E.4    Curcio, D.5    Ellis-Grosse, E.6    Loh, E.7    Rose, G.8
  • 7
    • 13644269309 scopus 로고    scopus 로고
    • Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
    • DOI 10.1164/rccm.200405-644ST
    • American Thoracic Society Infectious Diseases Society of America 2005 Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 388 416 10.1164/rccm.200405-644ST (Pubitemid 40227463)
    • (2005) American Journal of Respiratory and Critical Care Medicine , vol.171 , Issue.4 , pp. 388-416
  • 8
    • 43949117464 scopus 로고    scopus 로고
    • Correction of a reference to Clinical Laboratory Standards Institute interpretive criteria
    • DOI 10.1086/588056
    • MA Wikler MJ Ferraro 2008 Correction of a reference to clinical laboratory standards institute interpretive criteria Clin Infect Dis 46 1798 1789 10.1086/588056 18462124 (Pubitemid 351706789)
    • (2008) Clinical Infectious Diseases , vol.46 , Issue.11 , pp. 1798
    • Wikler, M.A.1    Ferraro, M.J.2
  • 9
    • 30044436792 scopus 로고    scopus 로고
    • Tigecycline
    • DOI 10.2165/00003495-200565180-00008
    • JE Frampton MP Curran 2005 Tigecycline Drugs 65 2623 2635 10.2165/00003495-200565180-00008 1:CAS:528:DC%2BD28Xit1Gqur4%3D 16392879 (Pubitemid 43049957)
    • (2005) Drugs , vol.65 , Issue.18 , pp. 2623-2635
    • Frampton, J.E.1    Curran, M.P.2
  • 10
    • 34250896679 scopus 로고    scopus 로고
    • Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii
    • DOI 10.1592/phco.27.7.980
    • JJ Schafer DA Goff KB Stevenson JE Mangino 2007 Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii Pharmacotherapy 27 980 987 10.1592/phco.27.7.980 1:CAS:528:DC%2BD2sXot1Gjuro%3D 17594203 (Pubitemid 46986684)
    • (2007) Pharmacotherapy , vol.27 , Issue.7 , pp. 980-987
    • Schafer, J.J.1    Goff, D.A.2    Stevenson, K.B.3    Mangino, J.E.4
  • 11
    • 31144469132 scopus 로고    scopus 로고
    • In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America
    • 10.1590/S1413-86702005000500001 16410885
    • AC Gales RN Jones SS Andrade AS Pereira HS Sader 2005 In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America Braz J Infect Dis 9 348 356 10.1590/S1413-86702005000500001 16410885
    • (2005) Braz J Infect Dis , vol.9 , pp. 348-356
    • Gales, A.C.1    Jones, R.N.2    Andrade, S.S.3    Pereira, A.S.4    Sader, H.S.5
  • 12
    • 33749525173 scopus 로고    scopus 로고
    • Effect of tigecycline on normal oropharyngeal and intestinal microflora
    • DOI 10.1128/AAC.00373-06
    • CE Nord E Sillerström E Wahlund 2006 Effect of tigecycline on normal oropharyngeal and intestinal microflora Antimicrob Agents Chemother 50 3375 3380 10.1128/AAC.00373-06 1:CAS:528:DC%2BD28XhtVylsbjL 17005820 (Pubitemid 44527513)
    • (2006) Antimicrobial Agents and Chemotherapy , vol.50 , Issue.10 , pp. 3375-3380
    • Nord, C.E.1    Silierstrom, E.2    Wahlund, E.3
  • 13
    • 38849130825 scopus 로고    scopus 로고
    • Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline
    • DOI 10.1086/526775
    • KB Anthony NO Fishman DR Linkin LB Gasink PH Edelstein E Lautenbach 2008 Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline Clin Infect Dis 46 567 570 10.1086/526775 18199038 (Pubitemid 351263497)
    • (2008) Clinical Infectious Diseases , vol.46 , Issue.4 , pp. 567-570
    • Anthony, K.B.1    Fishman, N.O.2    Linkin, D.R.3    Gasink, L.B.4    Edelstein, P.H.5    Lautenbach, E.6
  • 14
    • 34250828957 scopus 로고    scopus 로고
    • Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae
    • DOI 10.1592/phco.27.7.1052
    • MW Daly DJ Riddle NA Ledeboer WM Dunne DJ Ritchie 2007 Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae Pharmacotherapy 27 1052 1057 10.1592/phco.27.7.1052 1:CAS:528:DC%2BD2sXot1Gju70%3D 17594211 (Pubitemid 46986692)
    • (2007) Pharmacotherapy , vol.27 , Issue.7 , pp. 1052-1057
    • Daly, M.W.1    Riddle, D.J.2    Ledeboer, N.A.3    Dunne, W.M.4    Ritchie, D.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.